WorldLink Medical

A Note from Neal: What To Expect at the Part II BHRT Course

A Note from Neal: What To Expect at the Part II BHRT Course: A Note from Neal: What To Expect at the Part II BHRT Course

Neal Rouzier, MD

NEAL ROUZIER, M.D.

Dear Colleagues,

You will find a new level of confidence as you move from the basics of Part I to the advanced protocols in Part II. The Part II course provides the experienced practitioner with training that is essential for mastering complex cases. The course will serve as a short refresher, but will highlight new important therapies, clinical pearls, tricks of the trade, controversies and everything that I could not cram into Part I that you still need to know. The field of age management medicine continues to grow at a rapid rate, and we only seem to get busier, making it difficult to stay abreast of all the changes. This is why we’ve condensed an inordinate amount of material into 2 ½ days—in fact, there are over 1,300 slides of information (Yikes! I’ll talk fast).

My favorite part of this course are the informal discussion and question and answer session at the end of the day where we discuss anything that you want to discuss. This is one of the most interactive ways that new attendees expand their clinical knowledge by learning and sharing experiences, audience discussions, difficult cases, controversies, legal issues, suggestions, medical board issues, trials and tribulations from other seasoned attendees. I’ve yet to find anywhere else where can one go to participate in such a gathering and meeting of HRT practitioners that share their successes and challenges. This discussion is a wonderful prelude to the topics covered throughout the remainder of the weekend:

Section 1:
Antiaging, definitions of, and why we call it that. This is a review of the medical literature articles that shows us why we refer to BHRT as antiaging and provides credence for why we do what we do.

Section 2:
Longevity medicine and which hormones have a proven record of extending health, wellness, and longevity. Yes, optimization of HRT does extend life.

Section 3:
Making sense out of the many HRT studies, the critiques, and the rebuttals. Putting the pieces together will make you an expert on all the ifs, ands, and buts. It is the knowledge and command of this scientific literature (that your colleagues will never know) that makes you the expert.

Section 4:
The positive and negative articles on BHRT. Laying to rest estriol as the worthless metabolite it is. What the literature shows we should use and shouldn’t use, and disproving what many others are teaching without any basis in fact, ie estriol is safe.

Section 5:
“There are no studies that prove BHRT is different than synthetic HRT.” Baloney! Many studies contrast the BHRT with SHRT.

Section 6:
A literature review proving that HGH, testostereone, estrogen, progesterone, DHEA, and melatonin protect against cancer. The perfect solution to Obamacare.

Section 7:
This section is “R” rated for language and me acting out: Optimization of progesterone and case examples, multiple studies that prove transdermal cream is worthless and harmful, and saliva testing for monitoring therapy is fraught with error. Scientific studies prove where your levels should be for maximum protection, and where they should not be if one wants to protect against cancer. Case studies with labs show the good and bad.

Section 8:
New and different methods for raising testosterone in men and women besides creams: Oral, SQ, IM, HCG, Clomid, which are the cheapest and which are the best.

Section 9:
Oral vs. transdermal estrogen, relative risks for both, safest vs. most beneficial. Which, when, why and how the ESTHER study guides us.

Section 10:
A literature update of thyroid for cardiovascular protection and osteoporosis protection. So you think you know thyroid? More literature backing for why we do what we do.

Section 11:
What can you do to prevent and treat weight gain and bloating as far as hormones are concerned?

Sections 12:
Cardiovascular disease protection, cardiac markers, eicosinoids, diet, EFA’s, insulin, inflammation.

Section 13:
Cardiovascular case studies with management beyond statins.

Section 14:
Diagnosis and treatment of the most common premenopausal endocrinopathy that everyone fails (misses) to diagnosis, and it’s relation to CAD, breast CA, and uterine CA.

Section 15:
Treatment of osteoporosis beyond biphosphonates: E2, D3, Vit K, strontium, & ipraflavone. Measuring and monitoring NTX & CTX. Estrogen metabolites- do they or do they not predict breast cancer and should we waste money on testing? 2OH-E1 vs. 16αOH-E1?

Section 16:
Importance of optimization of estrogen in men too and the harm of suppression. The harm of giving progesterone to men that increases inflammatory cytokines and ED (what are they thinking)?

Section 17:
Cortisol for fatigue and CFS, how and when to use it, how to monitor it, and test it with ACTH.

Section 18:
Complex cases, labs, adjustments, fun and interesting cases, and lots of WWND (What Would Neal Do?)

Section 20:
Hormones and cancer, cause or protection? The myths & controversies of the oncogenic effects of hormones. Literature review showing protection against cancer by optimization of hormones.

Section 21:
Last hour is 100 pertinent questions and answers with discussion.
See you all in Salt Lake City!

– Neal

Share this post

Leave a comment

Your email address will not be published.